These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 940284)
1. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Schroeder ET; Anderson GH; Goldman SH; Streeten DH Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284 [TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942 [TBL] [Abstract][Full Text] [Related]
3. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403 [TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II blockade in the canine puppy under different salt-intake. Fiselier TJ; Monnens LA; Lameire NH; van Munster PJ; Peer PG; Leusen IR; Lijnen PJ Kidney Int; 1984 Dec; 26(6):823-9. PubMed ID: 6398382 [TBL] [Abstract][Full Text] [Related]
5. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects. Anderson GH; Streeten DH; Dalakos TG Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471 [TBL] [Abstract][Full Text] [Related]
6. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects. Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738 [TBL] [Abstract][Full Text] [Related]
7. Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites. Saito I; Saruta T; Eguchi T; Nakamura R; Kondo K; Iyori S; Kato E Jpn Heart J; 1978 Sep; 19(5):741-7. PubMed ID: 731936 [TBL] [Abstract][Full Text] [Related]
8. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients. Mimran A; Shaldon S; Barjon P; Mion C Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368 [TBL] [Abstract][Full Text] [Related]
9. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension. Fagard R; Lijnen P; Amery A; Reybrouck T Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588 [TBL] [Abstract][Full Text] [Related]
10. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs. Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771 [TBL] [Abstract][Full Text] [Related]
11. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes. Hata T; Ogihara T; Mikami H; Nakamaru M; Mandai T; Kumahara Y Eur J Clin Pharmacol; 1980 Oct; 18(4):295-9. PubMed ID: 7002566 [TBL] [Abstract][Full Text] [Related]
12. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients. Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848 [TBL] [Abstract][Full Text] [Related]
14. Studies on the effect of angiotensin II and of Des -angiotensin II on blood pressure, plasma renin activity and plasma aldosterone in the dog. Beckerhoff R; Uhlschmid G; Vetter W; Siegenthaler W Clin Sci Mol Med Suppl; 1976 Dec; 3():147s-150s. PubMed ID: 1071593 [TBL] [Abstract][Full Text] [Related]
15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163 [TBL] [Abstract][Full Text] [Related]
16. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients. Fagard R; Amery A; Lijnen P; Reybrouck T Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672 [TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II blockade by saralasin in normal man. Noth RH; Tan SY; Mulrow PJ J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056 [TBL] [Abstract][Full Text] [Related]
18. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)]. Beyer J; Liebau G; Steiner B; Hayduk K Klin Wochenschr; 1978 Sep; 56(17):859-64. PubMed ID: 713415 [TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system of the normothermic marmot. Kastner PR; Zatzman ML; South FE; Johnson JA Am J Physiol; 1977 Jul; 233(1):R37-43. PubMed ID: 195479 [TBL] [Abstract][Full Text] [Related]
20. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin. Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]